- $94.47m
- $159.76m
- $20.13m
- 48
- 82
- 95
- 88
Annual balance sheet for Phenixfin, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 68.2 | 56.5 | 69.4 | 22.8 | 5.99 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.12 | 0.744 | 2.62 | 1.42 | 5.51 |
Prepaid Expenses | |||||
Net Property, Plant And Equipment | — | — | 0.614 | 0.513 | 0.45 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Other Assets | |||||
Total Assets | 486 | 306 | 225 | 219 | 240 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 270 | 155 | 81.4 | 98 | 93 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 216 | 151 | 144 | 121 | 147 |
Total Liabilities & Shareholders' Equity | 486 | 306 | 225 | 219 | 240 |
Total Common Shares Outstanding |